B-precursor ALL
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab (NCT03480438) | Goethe University | 2018-06-01 |
| Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies (NCT02315612) | National Cancer Institute (NCI) | 2014-12-12 |
Track B-precursor ALL automatically
Every clearance here is in the API, with alerts when new ones post.